Advances in Immunotherapy for Tuberculosis Treatment

被引：44

作者：

Churchyard, Gavin J. ^{[1
,2
,3
]}

Kaplan, Gilla ^{[4
]}

Fallows, Dorothy ^{[4
]}

Wallis, Robert S. ^{[5
]}

Onyebujoh, Philip ^{[6
]}

Rook, Graham A. ^{[7
]}

机构：

[1] Aurum Inst Hlth Res, ZA-2041 Johannesburg, South Africa

[2] Univ KwaZulu Natal, Nelson R Mandela Sch Med, ZA-4041 Durban, South Africa

[3] Univ Cape Town, Fac Hlth Sci, ZA-7935 Cape Town, South Africa

[4] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA

[5] Pfizer Global Res & Dev, New London, CT 06320 USA

[6] WHO, Trop Dis Res, CH-1211 Geneva 27, Switzerland

[7] Royal Free & Univ Coll Med Sch, Ctr Infect Dis & Int Hlth, Windeyer Inst Med Sci, London W1P 7PP, England

来源：

CLINICS IN CHEST MEDICINE | 2009年 / 30卷 / 04期

关键词：

Tuberculosis; Immunotherapeutics; Antituberculous; Chemotherapy; Pulmonary infection; Immunopathology; TB treatment; NECROSIS-FACTOR-ALPHA; KILLED MYCOBACTERIUM-VACCAE; MULTIDRUG-RESISTANT TUBERCULOSIS; ADJUNCTIVE THALIDOMIDE THERAPY; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; IFN-GAMMA; T-CELLS; ANTITUBERCULOSIS TREATMENT; ANTIINFLAMMATORY ACTIVITY;

D O I：

10.1016/j.ccm.2009.08.009

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Immunotherapies have the potential to improve the outcome in all patients with tuberculosis (TB) including those with multidrug-resistant (MDR)-TB and extensively drug-resistant (XDR)-TB. Immunotherapy for TB may shorten duration of treatment and reduce pathology in individuals cured by chemotherapy, potentially preventing recurrence. Currently none of the available candidate agents have proof of efficacy for use in MDR-TB or XDR-TB. Further development and evaluation of existing immunotherapeutic agents is required to identify an effective agent that can be used adjunctively with chemotherapy to improve treatment outcomes for drug-susceptible TB, MDR-TB, and XDR-TB. With a range of potential immunotherapeutics, some of which have been produced to good manufacturing practice (GMP) standards and are registered for other indications in humans, the immunotherapy option should no longer be ignored.

引用

页码：769 / +

页数：15

共 101 条

[1] Influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during mycobacterium tuberculosis infection [J].

Algood, HMS ;

Lin, PL ;

Yankura, D ;

Jones, A ;

Chan, J ;

Flynn, JL .

JOURNAL OF IMMUNOLOGY, 2004, 172 (11) :6846-6857

[2] Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG fc [J].

Anthony, Robert M. ;

Nimmerjahn, Falk ;

Ashline, David J. ;

Reinhold, Vernon N. ;

Paulson, James C. ;

Ravetch, Jeffrey V. .

SCIENCE, 2008, 320 (5874) :373-376

[3] Identification of a receptor required for the anti-inflammatory activity of IVIG [J].

Anthony, Robert M. ;

Wermeling, Fredrik ;

Karlsson, Mikael C. I. ;

Ravetch, Jeffrey V. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (50) :19571-19578

[4]

Bilaçeroglu S, 1999, INT J TUBERC LUNG D, V3, P47

[5]

Bonilla Cesar A, 2008, PLoS One, V3, pe2957, DOI 10.1371/journal.pone.0002957

[6] RUTI: A new chance to shorten the treatment of latent tuberculosis infection [J].

Cardona, Pere-Joan .

TUBERCULOSIS, 2006, 86 (3-4) :273-289

[7] Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis [J].

Cardona, PJ ;

Arnat, I ;

Gordillo, S ;

Arcos, V ;

Guirado, E ;

Díaz, J ;

Vilaplana, C ;

Tapia, G ;

Ausina, V .

VACCINE, 2005, 23 (11) :1393-1398

[8] Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi [J].

Chen, ML ;

Pittet, MJ ;

Gorelik, L ;

Flavell, RA ;

Weissleder, R ;

von Boehmer, H ;

Khazaie, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (02) :419-424

[9]

CHURCHYARD GJ, 2007, EXPERT CONSULTATION

[10] Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol [J].

Condos, R ;

Rom, WN ;

Schluger, NW .

LANCET, 1997, 349 (9064) :1513-1515

← 1 2 3 4 5 6 7 8 9 10 →